The Board of Directors of NESTMEDIC SA, a joint-stock company, with its registered office in Wrocław (the “Company”), announces that the current report submitted by the Current Report No. 8/2017 as of today in the second paragraph, where the co-financing amounts are quoted. The submitted confidential information should be worded as follows:
“The total net value of the project: PLN6,932,005.98; the co-financing value: PLN4,958,888.98 where: (i) the maximum amount of co-financing for industrial research is PLN3.198.741,53, (ii) the maximum amount of co-financing for development works is PLN1.760.147,45.”
The remaining content of the report remains unchanged.
Legal basis:
Article 17 (1) of the Regulation (EU) No 596/2014 of the European Parliament and the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC
Adjustment of the amounts connected with the conclusion of the co-financing agreement with the NCRD
Current Report No. 8/2017/K
